X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE CADILA HEALTHCARE SUVEN LIFE/
CADILA HEALTHCARE
 
P/E (TTM) x 20.2 32.6 61.8% View Chart
P/BV x 3.7 6.5 57.9% View Chart
Dividend Yield % 1.0 0.7 137.4%  

Financials

 SUVEN LIFE   CADILA HEALTHCARE
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
CADILA HEALTHCARE
Mar-17
SUVEN LIFE/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs339460 73.6%   
Low Rs144305 47.3%   
Sales per share (Unadj.) Rs39.292.1 42.6%  
Earnings per share (Unadj.) Rs7.514.8 50.4%  
Cash flow per share (Unadj.) Rs8.818.5 47.5%  
Dividends per share (Unadj.) Rs2.003.20 62.5%  
Dividend yield (eoy) %0.80.8 99.0%  
Book value per share (Unadj.) Rs49.068.0 72.1%  
Shares outstanding (eoy) m127.281,023.74 12.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.24.2 148.2%   
Avg P/E ratio x32.425.8 125.3%  
P/CF ratio (eoy) x27.520.7 132.9%  
Price / Book Value ratio x4.95.6 87.6%  
Dividend payout %26.821.6 124.1%   
Avg Mkt Cap Rs m30,732391,581 7.8%   
No. of employees `0001.016.9 5.7%   
Total wages/salary Rs m41615,002 2.8%   
Avg. sales/employee Rs Th5,236.15,594.5 93.6%   
Avg. wages/employee Rs Th436.5890.1 49.0%   
Avg. net profit/employee Rs Th995.5899.9 110.6%   
INCOME DATA
Net Sales Rs m4,99594,295 5.3%  
Other income Rs m1941,286 15.0%   
Total revenues Rs m5,18995,581 5.4%   
Gross profit Rs m1,23319,036 6.5%  
Depreciation Rs m1673,750 4.5%   
Interest Rs m54450 12.0%   
Profit before tax Rs m1,20516,122 7.5%   
Minority Interest Rs m0338 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3 0.0%   
Tax Rs m2551,289 19.8%   
Profit after tax Rs m95015,168 6.3%  
Gross profit margin %24.720.2 122.2%  
Effective tax rate %21.28.0 264.7%   
Net profit margin %19.016.1 118.2%  
BALANCE SHEET DATA
Current assets Rs m4,98660,223 8.3%   
Current liabilities Rs m1,04253,058 2.0%   
Net working cap to sales %79.07.6 1,039.0%  
Current ratio x4.81.1 421.5%  
Inventory Days Days6170 87.3%  
Debtors Days Days3988 44.4%  
Net fixed assets Rs m3,12672,984 4.3%   
Share capital Rs m1271,024 12.4%   
"Free" reserves Rs m3,71768,576 5.4%   
Net worth Rs m6,23669,600 9.0%   
Long term debt Rs m43224,684 1.8%   
Total assets Rs m8,079152,207 5.3%  
Interest coverage x23.236.8 63.1%   
Debt to equity ratio x0.10.4 19.5%  
Sales to assets ratio x0.60.6 99.8%   
Return on assets %12.410.3 121.1%  
Return on equity %15.221.8 69.9%  
Return on capital %18.917.9 105.3%  
Exports to sales %87.50-   
Imports to sales %12.20-   
Exports (fob) Rs m4,371NA-   
Imports (cif) Rs m611NA-   
Fx inflow Rs m4,66621,280 21.9%   
Fx outflow Rs m94210,874 8.7%   
Net fx Rs m3,72410,406 35.8%   
CASH FLOW
From Operations Rs m92213,495 6.8%  
From Investments Rs m-619-29,103 2.1%  
From Financial Activity Rs m-69823,158 -3.0%  
Net Cashflow Rs m-3967,556 -5.2%  

Share Holding

Indian Promoters % 63.4 74.8 84.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 8.3 -  
FIIs % 0.0 5.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 11.0 331.8%  
Shareholders   37,287 44,069 84.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  BIOCON LTD  UNICHEM LAB  

Compare SUVEN LIFE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Jan 22, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS